Why Gilead Sciences, Inc., Wynn Resorts Ltd., and Boston Scientific Corporation Are Today's 3 Worst Stocks

From health care to gambling, these three names were the worst in the stock market today

Jun 9, 2014 at 7:43PM
Longview

In the absence of any major economic data, the stock market continued to gain ground today, with the S&P 500 Index (SNPINDEX:^GSPC) even ending at an all-time high. Three stocks, however, finished as standout laggards: Gilead Sciences (NASDAQ:GILD), Wynn Resorts (NASDAQ:WYNN), and Boston Scientific Corporation (NYSE:BSX) were each firmly in the red Monday. The S&P 500, for its part, tacked on 1 point, or less than 0.1%, to end at 1,951.

Shares of Gilead Sciences, whose flagship product, Sovaldi, treats hepatitis C, shed 4.1% today, as a new, deep-pocketed competitor threw its hat in the ring. Perhaps you've heard of Merck? Well, the $170 billion pharma giant was so impatient to jump-start a comprehensive hepatitis C treatment that it paid the highest ever premium in a health-care deal, according to Bloomberg, to acquire Idenix Pharmaceuticals today. The $3.85 billion acquisition rewarded Idenix investors to the tune of 229% today. Gilead Sciences, on the other hand, is now pressured to either lower the price of its $84,000 treatment or invest more heavily in Sovaldi to differentiate it from Merck's new combo offering.

Casino operators Wynn Resorts also had a rough day on Wall Street today, losing 2.9% by the ring of the closing bell. Wynn investors should count themselves lucky for the simple reason that the gaming company has firmly established itself in Macau, the 21st century's gambling capital of the world. But participating in China's exclusive and emerging gambling hotspot brings its own risks, and right now the biggest risk for investors is the possibility that the explosive growth in the region is slowing. After a decelerating month of revenue growth in May, Wells Fargo reported that Macau gaming revenue, by its estimates, continues to decelerate in early June.

Bostonscientificinterventionalstent

An interventional coronary stent. Source: Boston Scientific

Lastly, shares of Boston Scientific fell 2.8% Monday, kicking off the week on a bearish note. While revenue at Boston Scientific has been trending steadily lower for years -- a phenomenon no investor wants to see -- there's no real, compelling reason behind today's slump. The health care sector happened to be the second-worst performer in the stock market today, so Boston Scientific was already fighting an uphill battle Monday, but its long-term prospects aren't quite as dire. The company acquired Bayer's interventional division for $415 million last month, which should create operational synergies and complement its own interventional division ("interventional" products treat blood flow issues).

Invest in the next wave of health care innovation
The Economist compares this disruptive invention to the steam engine and the printing press. Business Insider says it's "the next trillion-dollar industry." And the technology behind is poised to set off one of the most remarkable health care revolutions in decades. The Motley Fool's exclusive research presentation dives into this technology's true potential, and its ability to make life-changing medical solutions never thought possible. To learn how you can invest in this unbelievable new technology, click here now to see our free report.

John Divine has no position in any stocks mentioned. You can follow him on Twitter, @divinebizkid, and on Motley Fool CAPS. @TMFDivine.

The Motley Fool recommends and owns shares of Gilead Sciences and Wells Fargo and has options on Wells Fargo. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.


Compare Brokers